Logo of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma)
Jamjoom Pharmaceuticals Factory Co.'s (Jamjoom Pharma) shareholders will vote on the board's recommendation on paying cash dividends at 15% of capital, or SAR 1.5 per share, for the second half of 2023, during the extraordinary general meeting (EGM), to be held on June 4, according to a Tadawul statement.
|
Dividend Details (H2 2023) |
|
|
Current capital |
SAR 700 mln |
|
Number of shares |
70 mln |
|
Dividend |
SAR 105 mln |
|
Percentage of capital |
15% (SAR 1.5 per share) |
|
Record date |
Shareholders of record and those registered with Edaa by the close of the second trading day following the record date |
|
Payment date |
To be set later |
|
2023 Dividends |
|
|
Total dividend |
SAR 175 mln |
|
Percentage of capital |
25% (SAR 2.5 per share) |
Shareholders will also vote on authorizing the board of directors to distribute interim dividends on a quarterly or semi-annually basis for 2024.
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}